Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by canadapieton Oct 08, 2019 3:06pm

82 Views

Post# 30208606

RE:RE:RE:RE:RE:RE:RE:RE:Trogarzo sales situation

Guys,

they are telling lies for over a year and now you are searching for reasons why the sp is tumbling???? Come on, ever thought why they didn't answer questions??? Why they didn't buy shares?? Why they themselve are following the numbers at "Bloomberg"???

Very, very amateurisch !!!!
The company exists how long ???,

Pathetic!!!!

Go go Mister PinnacleX

:-)

Bullboard Posts

Anaergia expands relationship with PepsiCo